Standard Life Aberdeen plc lifted its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 6.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,094,907 shares of the company’s stock after purchasing an additional 65,155 shares during the quarter. Standard Life Aberdeen plc owned 2.12% of Prestige Consumer Healthcare worth $41,492,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of PBH. Bank of Montreal Can lifted its position in Prestige Consumer Healthcare by 135.9% in the second quarter. Bank of Montreal Can now owns 3,067 shares of the company’s stock worth $118,000 after buying an additional 1,767 shares during the last quarter. Zions Bancorporation bought a new stake in Prestige Consumer Healthcare in the second quarter worth $137,000. BlueMountain Capital Management LLC bought a new stake in Prestige Consumer Healthcare in the second quarter worth $208,000. Public Employees Retirement Association of Colorado lifted its position in Prestige Consumer Healthcare by 73.8% in the third quarter. Public Employees Retirement Association of Colorado now owns 5,623 shares of the company’s stock worth $213,000 after buying an additional 2,387 shares during the last quarter. Finally, Parametrica Management Ltd bought a new stake in Prestige Consumer Healthcare in the third quarter worth $217,000.
In other news, EVP Timothy Connors sold 34,000 shares of Prestige Consumer Healthcare stock in a transaction on Monday, November 19th. The stock was sold at an average price of $38.25, for a total transaction of $1,300,500.00. Following the completion of the sale, the executive vice president now directly owns 25,775 shares in the company, valued at $985,893.75. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.14% of the stock is currently owned by company insiders.
Shares of PBH opened at $38.82 on Monday. The firm has a market capitalization of $2.01 billion, a P/E ratio of 15.05, a P/E/G ratio of 1.92 and a beta of 1.01. Prestige Consumer Healthcare Inc has a 52-week low of $27.84 and a 52-week high of $48.24. The company has a quick ratio of 1.38, a current ratio of 2.15 and a debt-to-equity ratio of 1.59.
Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, November 1st. The company reported $0.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.63 by $0.02. Prestige Consumer Healthcare had a return on equity of 11.82% and a net margin of 33.38%. The company had revenue of $239.36 million during the quarter, compared to the consensus estimate of $236.28 million. During the same period last year, the company earned $0.61 earnings per share. Prestige Consumer Healthcare’s revenue was down 7.2% on a year-over-year basis. On average, sell-side analysts anticipate that Prestige Consumer Healthcare Inc will post 2.88 earnings per share for the current fiscal year.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Featured Story: What strategies should day traders use to execute a trade?
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.